<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149695">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01940588</url>
  </required_header>
  <id_info>
    <org_study_id>1 - bjohnson</org_study_id>
    <nct_id>NCT01940588</nct_id>
  </id_info>
  <brief_title>Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence</brief_title>
  <official_title>Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Upstate Medical University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid Dependent Patients who have failed back surgery syndrome are detoxified and treated
      with a neuropsychoanalytic paradigm.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Improvement of pain</measure>
    <time_frame>Six months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Detoxified patients followed for whether their pain improved.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Focus - Improvement of Pain</condition>
  <arm_group>
    <arm_group_label>Neuropsychoanalytic treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Outpatient detoxification, intensive neuropsychoanalytic therapy, low dose naltrexone, monthly evaluations for six months - case series approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuropsychoanalytic therapy</intervention_name>
    <arm_group_label>Neuropsychoanalytic treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have failed back surgery syndrome.

          2. Have evidence of Opioid Dependence by meeting DSM-IV criteria and by Drug Abuse
             Screening Test &gt; 4.  (In case of a difference in these two measures, clinical staff
             will talk with the patient to adjudicate the difference.)

          3. Over 18

          4. Be able to understand spoken and written English

          5. Reside within 30 miles of the site of treatment for ease of followup

          6. Have health insurance or other ability to pay for treatment

        Exclusion Criteria:

          1. Homeless

          2. Unable to give consent (e.g. neurological disorders, dementia, psychosis)

          3. Co-occurring incapacitating psychiatric disorder such as schizophrenia

          4. Pregnant

          5. Financial incentive to stay ill, such as a pending disability claim

          6. Member of a vulnerable population, including prisoners
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Johnson, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of New York - Upstate Medical University</affiliation>
  </overall_official>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 11, 2013</lastchanged_date>
  <firstreceived_date>September 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Failed Back Surgery Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
